InvestorsHub Logo
Followers 26
Posts 2878
Boards Moderated 0
Alias Born 12/05/2021

Re: bas2020 post# 439890

Tuesday, 02/01/2022 11:45:13 AM

Tuesday, February 01, 2022 11:45:13 AM

Post# of 701432
wow what happened with Anavex today it reported positive top-line results from the Phase 3 randomized, double-blind, placebo-controlled AVATAR trial and still got slammed down.

Just comes to show how bizarre the market is slamming down biotechs on positive topline data nowadays. Anavex is not the only biotech going through this. From my perspective, this is what would have happened with Northwest if they would have "only" reported positive topline data without a journal.

heck what will this market environment mean for NWBO SP after the journal?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News